This grant opportunity (PAR-25-145) from the NIH seeks proposals for clinical characterization of adverse sequelae resulting from cancer therapy and the development of mechanism-based interventional strategies. The funding opportunity is a Clinical Trial Optional R01 grant.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.